Skip to main content
Premium Trial:

Request an Annual Quote

IP Update: Recent Patents Awarded to Alnylam, Quark, Qiagen, and More


Title: RNA Interference-mediating Small RNA Molecules

Patent Number: 8,853,384

Filed: Dec. 2, 2009

Lead Inventor: Thomas Tuschl, Max Planck Institute

Title: Transgenic Plant-based Methods for Plant Pests Using RNAi

Patent Number: 8,853,489

Filed: Sept.18, 2006

Lead Inventor: Romaan Raemaekers, Devgen (Syngenta)

Title: Lipid-formulated Compositions and Methods for Inhibiting Expression of Eg5 and VEGF Genes

Patent Number: 8,859,516

Filed: Sept.10, 2010

Lead Inventor: David Bumcrot, Alnylam Pharmaceuticals

Title: Methods Targeting miR-33 microRNAs for Regulating Lipid Metabolism

Patent Number: 8,859,519

Filed: Aug. 25, 2011

Inventor: Anders Naar, Harvard Medical School

Title: Oligomeric Compounds and Compositions for Use in Modulation of Small, Non-coding RNAs

Patent Number: 8,859,521

Filed: Dec. 30, 2013

Lead Inventor: Frank Bennett, Regulus Therapeutics

Title: Use of RNAi Inhibiting PARP Activity for the Manufacture of a Medicament for the Treatment of Cancer

Patent Number: 8,859,562

Filed: Sept. 15, 2006

Inventor: Thomas Helleday, University of Sheffield

Title: Modified Short Interfering RNA

Patent Number: 8,859,749

Filed: March 8, 2006

Lead Inventor: Ioanna Andreou, Qiagen

Title: RNAi Modulation of RSV and Therapeutic Uses Thereof

Patent Number: 8,859,750

Filed: March 29, 2012

Lead Inventor: Rachel Meyers, Alnylam Pharmaceuticals

Title: Oligonucleotide Compounds Comprising Non-nucleotide Overhangs

Patent Number: 8,859,751

Filed: Jan. 6, 2012

Lead Inventor: Sharon Nachum, Quark Pharmaceuticals

Title: siRNA-based Therapy of Fibrodysplasia Ossificans Progressiva

Patent Number: 8,859,752

Filed: Oct. 17, 2012

Lead Inventor: Frederick Kaplan, University of Pennsylvania

The Scan

Comfort of Home

The Guardian reports that AstraZeneca is to run more clinical trials from people's homes with the aim of increasing participant diversity.

Keep Under Control

Genetic technologies are among the tools suggested to manage invasive species and feral animals in Australia, Newsweek says.

Just Make It

The New York Times writes that there is increased interest in applying gene synthesis to even more applications.

Nucleic Acids Research Papers on OncoDB, mBodyMap, Genomicus

In Nucleic Acids Research this week: database to analyze large cancer datasets, human body microbe database, and more.